1,585
Views
8
CrossRef citations to date
0
Altmetric
Clinical Study

Very early withdrawal from treatment in patients starting peritoneal dialysis

, , , , , & show all
Pages 8-14 | Received 28 May 2017, Accepted 14 Dec 2017, Published online: 03 Jan 2018

References

  • Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982.
  • Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9:523–528.
  • Descoeudres B, Koller MT, Garzoni D, et al. Contribution of early failure to outcome on peritoneal dialysis. Perit Dial Int. 2008;28:259–267.
  • Masakane I, Tsubakihara Y, Akiba T, et al. The most recent trends of peritoneal dialysis in Japan. Perit Dial Int. 2008;28(Suppl 3):S27–S31.
  • Mizuno M, Ito Y, Tanaka A, et al. Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol. 2011;15:727–737.
  • Sanabria M, Devia M, Hernandez G, et al. Outcomes of a peritoneal dialysis program in remote communities within Colombia. Perit Dial Int. 2015;35:52–61.
  • Kolesnyk I, Dekker FW, Boeschoten EW, et al. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int. 2010;30:170–177.
  • Bechade C, Guittet L, Evans D, et al. Early failure in patients starting peritoneal dialysis: a competing risks approach. Nephrol Dial Transplant. 2014;29:2127–2135.
  • Yang SF, Liu CJ, Yang WC, et al. The risk factors and the impact of hernia development on technique survival in peritoneal dialysis patients: a population-based cohort study. Perit Dial Int. 2015;35:351–359.
  • Xia X, He F, Wu X, et al. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis. 2014;64:257–264.
  • Kawaguchi Y, Ishizaki T, Imada A, etet al. Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan. Perit Dial Int. 2003;23(Suppl 2):S175–S177.
  • Hurst H, Summers A, Beaver K, et al. Living with encapsulating peritoneal sclerosis (EPS): the patient's perspective. Perit Dial Int. 2014;34:758–765.
  • Panagoutsos S, Kantartzi K, Passadakis P, et al. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin Nephrol. 2006;65:43–47.
  • Mizuno M, Ito Y, Suzuki Y, et al. Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry. Clin Exp Nephrol. 2016;20:960–971.
  • Koc Y, Unsal A, Ahbap E, et al. Clinical outcome of diabetic peritoneal dialysis patients and evaluation of factors affecting mortality: a single centre's experience from Turkey. J Ren Care. 2011;37:94–100.
  • Chan HW, Clayton PA, McDonald SP, et al. Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999–2008. Clin J Am Soc Nephrol. 2012;7:775–781.
  • Pulliam J, Li NC, Maddux F, et al. First-year outcomes of incident peritoneal dialysis patients in the United States. Am J Kidney Dis. 2014;64:761–769.
  • Findlay MD, Donaldson K, Doyle A, et al. Factors influencing withdrawal from dialysis: a national registry study. Nephrol Dial Transplant. 2016;31:2041–2048.
  • Udayaraj UP, Steenkamp R, Caskey FJ, et al. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53:70–78.
  • Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, et al. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005;20:1693–1701.
  • Hazama T, Fukami K, Yamagishi S, et al. Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patients. Ther Apher Dial. 2014;18:391–397.
  • Shahid M, Sun RL, Liu Y, et al. Is high high-density lipoprotein cholesterol beneficial for premature coronary heart disease? A meta-analysis. Eur J Prev Cardiolog. 2016;23:704–713.
  • Ko DT, Alter DA, Guo H, et al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions. The CANHEART Study. J Am Coll Cardiol. 2016;68:2073–2083.
  • Reiss AB, Voloshyna I, De Leon J, et al. Cholesterol metabolism in CKD. Am J Kidney Dis. 2015;66:1071–1082.
  • Rogacev KS, Zawada AM, Emrich I, et al. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vas Biol. 2014;34:2120–2127.
  • Obi Y, Rhee CM, Mathew AT, et al. Residual kidney function decline and mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2016;27:3758–3768.
  • Obi Y, Streja E, Rhee CM, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis. 2016;68:256–265.
  • Lu YH, Hwang JC, Jiang MY, et al. Comparison of the impact of “fast decline” in residual renal function and “initial anuria” on long-term outcomes in CAPD patients. Perit Dial Int. 2015;35:172–179.
  • Han SH, Lee SC, Kang EW, et al. Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis. Perit Dial Int. 2012;32:149–158.
  • Sikorska D, Pawlaczyk K, Olewicz-Gawlik A, et al. The importance of residual renal function in peritoneal dialysis. Int Urol Nephrol. 2016;48:2101–2108.